The Korean Journal of Physiology and Pharmacology

The Korean Society of Pharmacology (대한약리학회)
권호 표지
DOI QR코드

DOI QR Code

The Protective Effect of Epigallocatechin-3 Gallate on Ischemia/Reperfusion Injury in Isolated Rat Hearts: An ex vivo Approach

  • Piao, Cheng Shi (Department of Pharmacology and Cardiovascular Research Institute, School of Medicine, Chonbuk National University) ;
  • Kim, Do-Sung (Department of Pharmacology and Cardiovascular Research Institute, School of Medicine, Chonbuk National University) ;
  • Ha, Ki-Chan (Department of Pharmacology and Cardiovascular Research Institute, School of Medicine, Chonbuk National University) ;
  • Kim, Hyung-Ryong (Department of Dental Pharmacology, School of Dentistry, Wonkwang University) ;
  • Chae, Han-Jung (Department of Pharmacology and Cardiovascular Research Institute, School of Medicine, Chonbuk National University) ;
  • Chae, Soo-Wan (Department of Pharmacology and Cardiovascular Research Institute, School of Medicine, Chonbuk National University)
  • Received : 2011.07.18
  • Accepted : 2011.09.24
  • Published : 2010.10.30
Download PDF
⟨ Previous Next ⟩

Abstract

The aim of this study was to evaluate the preventive role of epigallocatechin-3 gallate (EGCG, a derivative of green tea) in ischemia/reperfusion (I/R) injury of isolated rat hearts. It has been suggested that EGCG has beneficial health effects, including prevention of cancer and heart disease, and it is also a potent antioxidant. Rat hearts were subjected to 20 min of normoxia, 20 min of zero-flow ischemia and then 50 min of reperfusion. EGCG was perfused 10 min before ischemia and during the whole reperfusion period. EGCG significantly increased left ventricular developed pressure (LVDP) and increased maximum positive and negative dP/dt (+/-dP/dtmax). EGCG also significantly increased the coronary flow (CF) at baseline before ischemia and at the onset of the reperfusion period. Moreover, EGCG decreased left ventricular end diastolic pressure (LVEDP). This study showed that lipid peroxydation was inhibited and Mn-SOD and catalase expressions were increased in the presence of EGCG. In addition, EGCG increased levels of Bcl-2, Mn-superoxide dismutase (SOD), and catalase expression and decreased levels of Bax and increased the ratio of Bcl-2/Bax in isolated rat hearts. Cleaved caspase-3 was decreased after EGCG treatment. EGCG markedly decreased the infarct size while attenuating the increase in lactate dehydrogenase (LDH) levels in the effluent. In summary, we suggest that EGCG has a protective effect on I/R-associated hemodynamic alteration and injury by acting as an antioxidant and anti-apoptotic agent in one.

Keywords

References

  1. Ostadal B. The past, the present and the future of experimental research on myocardial ischemia and protection. Pharmacol Rep. 2009;61:3-12. https://doi.org/10.1016/S1734-1140(09)70002-7
  2. Buja LM. Myocardial ischemia and reperfusion injury. Cardiovasc Pathol. 2005;14:170-175. https://doi.org/10.1016/j.carpath.2005.03.006
  3. Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev. 2008;88:581-609 https://doi.org/10.1152/physrev.00024.2007
  4. Misra MK, Sarwat M, Bhakuni P, Tuteja R, Tuteja N. Oxidative stress and ischemic myocardial syndromes. Med Sci Monit. 2009;15:RA209-219.
  5. Zweier JL, Flaherty JT, Weisfeldt ML. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci USA. 1987;84:1404-1407. https://doi.org/10.1073/pnas.84.5.1404
  6. Zweier JL, Talukder MA. The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res. 2006;70:181-190 https://doi.org/10.1016/j.cardiores.2006.02.025
  7. Naslund U, Haggmark S, Johansson G, Marklund SL, Reiz S, Oberg A. Superoxide dismutase and catalase reduce infarct size in a porcine myocardial occlusion-reperfusion model. J Mol Cell Cardiol. 1986;18:1077-1084 https://doi.org/10.1016/S0022-2828(86)80294-2
  8. Zhao ZQ, Nakamura M, Wang NP, Wilcox JN, Shearer S, Ronson RS, Guyton RA, Vinten-Johansen J. Reperfusion induces myocardial apoptotic cell death. Cardiovasc Res. 2000; 45:651-660. https://doi.org/10.1016/S0008-6363(99)00354-5
  9. Zhao ZQ, Morris CD, Budde JM, Wang NP, Muraki S, Sun HY, Guyton RA. Inhibition of myocardial apoptosis reduces infarct size and improves regional contractile dysfunction during reperfusion. Cardiovasc Res. 2003;59:132-142. https://doi.org/10.1016/S0008-6363(03)00344-4
  10. Kris-Etherton PM, Keen CL. Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Curr Opin Lipidol. 2002;13:41-49. https://doi.org/10.1097/00041433-200202000-00007
  11. Lin JK, Liang YC, Lin-Shiau SY. Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade. Biochem Pharmacol. 1999;58:911-915. https://doi.org/10.1016/S0006-2952(99)00112-4
  12. Peairs A, Dai R, Gan L, Shimp S, Rylander MN, Li L, Reilly CM. Epigallocatechin-3-gallate (EGCG) attenuates inflammation in MRL/lpr mouse mesangial cells. Cell Mol Immunol. 2010;7:123-132 https://doi.org/10.1038/cmi.2010.1
  13. Serafini M, Ghiselli A, Ferro-Luzzi A. In vivo antioxidant effect of green and black tea in man. Eur J Clin Nutr. 1996;50:28-32.
  14. Nagle DG, Ferreira D, Zhou YD. Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives. Phytochemistry. 2006;67:1849-1855. https://doi.org/10.1016/j.phytochem.2006.06.020
  15. Lorenz M, Hellige N, Rieder P, Kinkel HT, Trimpert C, Staudt A, Felix SB, Baumann G, Stangl K, Stangl V. Positive inotropic effects of epigallocatechin-3-gallate (EGCG) involve activation of $Na^{+}/H^{+}$ and $Na^{+}/Ca^{2+}$ exchangers. Eur J Heart Fail. 2008;10:439-445. https://doi.org/10.1016/j.ejheart.2008.03.004
  16. Townsend PA, Scarabelli TM, Pasini E, Gitti G, Menegazzi M, Suzuki H, Knight RA, Latchman DS, Stephanou A. Epigallocatechin- 3-gallate inhibits STAT-1 activation and protects cardiac myocytes from ischemia/reperfusion-induced apoptosis. FASEB J. 2004;18:1621-1623. https://doi.org/10.1096/fj.04-1716fje
  17. Miura Y, Chiba T, Tomita I, Koizumi H, Miura S, Umegaki K, Hara Y, Ikeda M, Tomita T. Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J Nutr. 2001;131:27-32. https://doi.org/10.1093/jn/131.1.27
  18. Potenza MA, Marasciulo FL, Tarquinio M, Tiravanti E, Colantuono G, Federici A, Kim JA, Quon MJ, Montagnani M. EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab. 2007;292:E1378-1387. https://doi.org/10.1152/ajpendo.00698.2006
  19. Piper HM, Abdallah Y, Schafer C. The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovasc Res. 2004;61:365-371. https://doi.org/10.1016/j.cardiores.2003.12.012
  20. Piper HM, Garcia-Dorado D, Ovize M. A fresh look at reperfusion injury. Cardiovasc Res. 1998;38:291-300. https://doi.org/10.1016/S0008-6363(98)00033-9
  21. Hirai M, Hotta Y, Ishikawa N, Wakida Y, Fukuzawa Y, Isobe F, Nakano A, Chiba T, Kawamura N. Protective effects of EGCg or GCg, a green tea catechin epimer, against postischemic myocardial dysfunction in guinea-pig hearts. Life Sci. 2007; 80:1020-1032. https://doi.org/10.1016/j.lfs.2006.11.032
  22. Song DK, Jang Y, Kim JH, Chun KJ, Lee D, Xu Z. Polyphenol (-)-epigallocatechin gallate during ischemia limits infarct size via mitochondrial K(ATP) channel activation in isolated rat hearts. J Korean Med Sci. 2010;25:380-386 https://doi.org/10.3346/jkms.2010.25.3.380
  23. Rajak S, Banerjee SK, Sood S, Dinda AK, Gupta YK, Gupta SK, Maulik SK. Emblica officinalis causes myocardial adaptation and protects against oxidative stress in ischemic-reperfusion injury in rats. Phytother Res. 2004;18:54-60 https://doi.org/10.1002/ptr.1367
  24. Katiyar S, Elmets CA, Katiyar SK. Green tea and skin cancer: photoimmunology, angiogenesis and DNA repair. J Nutr Biochem. 2007;18:287-296. https://doi.org/10.1016/j.jnutbio.2006.08.004
  25. Devika PT, Stanely Mainzen Prince P. (-)Epigallocatechingallate protects the mitochondria against the deleterious effects of lipids, calcium and adenosine triphosphate in isoproterenol induced myocardial infarcted male Wistar rats. J Appl Toxicol. 2008;28:938-944.
  26. Loor G, Kondapalli J, Iwase H, Chandel NS, Waypa GB, Guzy RD, Vanden Hoek TL, Schumacker PT. Mitochondrial oxidant stress triggers cell death in simulated ischemia-reperfusion. Biochim Biophys Acta. 2011;1813:1382-1394. https://doi.org/10.1016/j.bbamcr.2010.12.008
  27. Jones SP, Hoffmeyer MR, Sharp BR, Ho YS, Lefer DJ. Role of intracellular antioxidant enzymes after in vivo myocardial ischemia and reperfusion. Am J Physiol Heart Circ Physiol. 2003;284:H277-282. https://doi.org/10.1152/ajpheart.00236.2002
  28. Buja LM, Entman ML. Modes of myocardial cell injury and cell death in ischemic heart disease. Circulation. 1998;98:1355- 1357. https://doi.org/10.1161/01.CIR.98.14.1355
  29. Aneja R, Hake PW, Burroughs TJ, Denenberg AG, Wong HR, Zingarelli B. Epigallocatechin, a green tea polyphenol, attenuates myocardial ischemia reperfusion injury in rats. Mol Med. 2004;10:55-62. https://doi.org/10.1007/s00894-003-0166-5
  30. Vila-Petroff M, Salas MA, Said M, Valverde CA, Sapia L, Portiansky E, Hajjar RJ, Kranias EG, Mundina-Weilenmann C, Mattiazzi A. CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury. Cardiovasc Res. 2007;73:689-698. https://doi.org/10.1016/j.cardiores.2006.12.003
  31. Piao CS, Gao S, Lee GH, Kim do S, Park BH, Chae SW, Chae HJ, Kim SH. Sulforaphane protects ischemic injury of hearts through antioxidant pathway and mitochondrial K(ATP) channels. Pharmacol Res. 2010;61:342-348. https://doi.org/10.1016/j.phrs.2009.11.009
  32. Dorn GW 2nd. Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling. Cardiovasc Res. 2009;81:465-473.
  33. Zhong H, Xin H, Wu LX, Zhu YZ. Salidroside attenuates apoptosis in ischemic cardiomyocytes: a mechanism through a mitochondria-dependent pathway. J Pharmacol Sci. 2010;114: 399-408. https://doi.org/10.1254/jphs.10078FP
  34. Kim DS, Kim HR, Woo ER, Hong ST, Chae HJ, Chae SW. Inhibitory effects of rosmarinic acid on adriamycin-induced apoptosis in H9c2 cardiac muscle cells by inhibiting reactive oxygen species and the activations of c-Jun N-terminal kinase and extracellular signal-regulated kinase. Biochem Pharmacol. 2005;70:1066-1078. https://doi.org/10.1016/j.bcp.2005.06.026

Cited by

  1. Oxidative stress and cardiovascular health: therapeutic potential of polyphenols vol.91, pp.3, 2013, https://doi.org/10.1139/cjpp-2012-0252
  2. Polyphenols: Benefits to the Cardiovascular System in Health and in Aging vol.5, pp.10, 2011, https://doi.org/10.3390/nu5103779
  3. Molecular Targets in Alzheimer's Disease: From Pathogenesis to Therapeutics vol.2015, pp.None, 2011, https://doi.org/10.1155/2015/760758
  4. Polyphenon-60 ameliorates metabolic risk factors, oxidative stress, and proinflammatory cytokines and modulates apoptotic proteins to protect the heart against streptozotocin-induced apoptosis vol.2, pp.2, 2015, https://doi.org/10.1016/j.ejbas.2015.03.003
  5. Epigallocatechin-3-gallate and zinc provide anti-apoptotic protection against hypoxia/reoxygenation injury in H9c2 rat cardiac myoblast cells vol.12, pp.2, 2011, https://doi.org/10.3892/mmr.2015.3603
  6. 천연물의 심혈관질환에 대한 약리학적 효과 vol.59, pp.4, 2011, https://doi.org/10.17480/psk.2015.59.4.137
  7. Green tea consumption and risk of cardiovascular and ischemic related diseases: A meta-analysis vol.202, pp.None, 2011, https://doi.org/10.1016/j.ijcard.2014.12.176
  8. Epigallocatechin gallate exerts protective effects against myocardial ischemia/reperfusion injury through the PI3K/Akt pathway-mediated inhibition of apoptosis and the restoration of the autophagic fl vol.38, pp.1, 2011, https://doi.org/10.3892/ijmm.2016.2615
  9. (−)-Epigallocatechin-3-gallate attenuates myocardial injury induced by ischemia/reperfusion in diabetic rats and in H9c2 cells under hyperglycemic conditions vol.40, pp.2, 2011, https://doi.org/10.3892/ijmm.2017.3014
  10. Epigallocatechin Gallate Reduces Ischemia/Reperfusion Injury in Isolated Perfused Rabbit Hearts vol.19, pp.2, 2011, https://doi.org/10.3390/ijms19020628
  11. Recent Advances in the Understanding of the Health Benefits and Molecular Mechanisms Associated with Green Tea Polyphenols vol.67, pp.4, 2019, https://doi.org/10.1021/acs.jafc.8b06146
  12. Pharmacology of Catechins in Ischemia-Reperfusion Injury of the Heart vol.10, pp.9, 2011, https://doi.org/10.3390/antiox10091390